Severe SARS-CoV-2 Pneumonia and Pneumomediastinum/Pneumothorax: A Prospective Observational Study in an Intermediate Respiratory Care Unit
Journal of Intensive Care Medicine · 2023
DOI: 10.1177/08850666231180165 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Intensive Care Medicine, 2023. Verfasst von Miguel Lorente-González und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, Intermediate Respiratory Care Unit, Hospital de Emergencias Enfermera Isabel Zendal [Nurse Isabel Zendal Emergency Hospital…. Hauptthemen laut MEDLINE: COVID-19, Mediastinal Emphysema, Pneumothorax, Pneumonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The occurrence of pneumomediastinum (PM) and/or pneumothorax (PTX) in patients with severe pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was evaluated.
Methods
This was a prospective observational study conducted in patients admitted to the intermediate respiratory care unit (IRCU) of a COVID-19 monographic hospital in Madrid (Spain) between December 14, 2020 and September 28, 2021. All patients had a diagnosis of severe SARS-CoV-2 pneumonia and required noninvasive respiratory support (NIRS): high-flow nasal cannula (HFNC), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP). The incidences of PM and/or PTX, overall and by NIRS, and their impact on the probabilities of invasive mechanical ventilation (IMV) and death were studied.
Results
A total of 1306 patients were included. 4.3% (56/1306) developed PM/PTX, 3.8% (50/1306) PM, 1.6% (21/1306) PTX, and 1.1% (15/1306) PM + PTX. 16.1% (9/56) of patients with PM/PTX had HFNC alone, while 83.9% (47/56) had HFNC + CPAP/BiPAP. In comparison, 41.7% (521/1250) of patients without PM/PTX had HFNC alone (odds ratio [OR] 0.27; 95% confidence interval [95% CI] 0.13-0.55; p < .001), while 58.3% (729/1250) had HFNC + CPAP/BiPAP (OR 3.73; 95% CI 1.81-7.68; p < .001). The probability of needing IMV among patients with PM/PTX was 67.9% (36/53) (OR 7.46; 95% CI 4.12-13.50; p < .001), while it was 22.1% (262/1185) among patients without PM/PTX. Mortality among patients with PM/PTX was 33.9% (19/56) (OR 4.39; 95% CI 2.45-7.85; p < .001), while it was 10.5% (131/1250) among patients without PM/PTX.
Conclusions
In patients admitted to the IRCU for severe SARS-CoV-2 pneumonia requiring NIRS, incidences of PM/PTX, PM, PTX, and PM + PTX were observed to be 4.3%, 3.8%, 1.6%, and 1.1%, respectively. Most patients with PM/PTX had HFNC + CPAP/BiPAP as the NIRS device, much more frequently than patients without PM/PTX. The probabilities of IMV and death among patients with PM/PTX were 67.9% and 33.9%, respectively, higher than those observed in patients without PM/PTX, which were 22.1% and 10.5%, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pneumology, Intermediate Respiratory Care Unit, Hospital de Emergencias Enfermera Isabel Zendal [Nurse Isabel Zendal Emergency Hospital], Madrid, Madrid, Spain.
- Department of Emergency Medicine, Intermediate Respiratory Care Unit, Hospital de Emergencias Enfermera Isabel Zendal [Nurse Isabel Zendal Emergency Hospital], Madrid, Madrid, Spain.
- Department of Internal Medicine, Intermediate Respiratory Care Unit, Hospital de Emergencias Enfermera Isabel Zendal [Nurse Isabel Zendal Emergency Hospital], Madrid, Madrid, Spain.
- Department of Anaesthesiology and Resuscitation, Intermediate Respiratory Care Unit, Hospital de Emergencias Enfermera Isabel Zendal [Nurse Isabel Zendal Emergency Hospital], Madrid, Madrid, Spain.
- Faculty of Medicine, Universidad Autónoma de Madrid [Autónoma University of Madrid], Madrid, Madrid, Spain.
ORCID-Profile: Miguel Lorente-González, Joaquín Hernández-Núñez
Zitieren
APA
Lorente-González, M., Terán-Tinedo, J. R., Zevallos-Villegas, A., Laorden, D., Mariscal-Aguilar, P., Suárez-Ortiz, M., Cano-Sanz, E., Ortega-Fraile, M. Á., Hernández-Núñez, J., Falcone, A., Saiz-Lou, E. M., Plaza-Moreno, M. C., García-Fadul, C., Valle-Falcones, M., Sánchez-Azofra, A., Funes-Moreno, C., De-La-Calle-Gil, I., Navarro-Casado, R., Carballo-López, D., …, & Landete, P. (2023). Severe SARS-CoV-2 Pneumonia and Pneumomediastinum/Pneumothorax: A Prospective Observational Study in an Intermediate Respiratory Care Unit. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666231180165
Vancouver
Lorente-González M, Terán-Tinedo JR, Zevallos-Villegas A, Laorden D, Mariscal-Aguilar P, Suárez-Ortiz M, et al. Severe SARS-CoV-2 Pneumonia and Pneumomediastinum/Pneumothorax: A Prospective Observational Study in an Intermediate Respiratory Care Unit. Journal of Intensive Care Medicine. 2023. doi:10.1177/08850666231180165
BibTeX
@article{LorenteGonzlez2023,
author = {Lorente-González, Miguel and Terán-Tinedo, José Rafael and Zevallos-Villegas, Annette and Laorden, Daniel and Mariscal-Aguilar, Pablo and Suárez-Ortiz, Miguel and Cano-Sanz, Eduardo and Ortega-Fraile, María Ángeles and Hernández-Núñez, Joaquín and Falcone, Adalgisa and Saiz-Lou, Elena María and Plaza-Moreno, María Cristina and García-Fadul, Christian and Valle-Falcones, Manuel and Sánchez-Azofra, Ana and Funes-Moreno, Clotilde and De-La-Calle-Gil, Isabel and Navarro-Casado, Rosalía and Carballo-López, Daniel and Gholamian-Ovejero, Soraya and Gallego-Rodríguez, Berta and Villén-Villegas, Tomás and Landete, Pedro},
title = {Severe SARS-CoV-2 Pneumonia and Pneumomediastinum/Pneumothorax: A Prospective Observational Study in an Intermediate Respiratory Care Unit},
journal = {Journal of Intensive Care Medicine},
year = {2023},
doi = {10.1177/08850666231180165}
}
EUVIMED